SII INVESTMENTS INC/WI - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 78 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2015. The put-call ratio across all filers is 97.39 and the average weighting 0.8%.

Quarter-by-quarter ownership
SII INVESTMENTS INC/WI ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2017$30,000
-18.9%
71,0150.0%0.00%0.0%
Q2 2017$37,000
-28.8%
71,015
-21.4%
0.00%
-50.0%
Q1 2017$52,000
-5.5%
90,3150.0%0.00%0.0%
Q4 2016$55,000
-32.9%
90,3150.0%0.00%
-33.3%
Q3 2016$82,000
+115.8%
90,315
+27.2%
0.01%
+100.0%
Q2 2016$38,000
-55.8%
71,015
-21.4%
0.00%
-62.5%
Q1 2016$86,000
-9.5%
90,315
+27.2%
0.01%
-33.3%
Q4 2015$95,000
-53.7%
71,015
-21.4%
0.01%
-50.0%
Q3 2015$205,000
+88.1%
90,315
+32.8%
0.02%
+84.6%
Q2 2015$109,0000.0%68,0150.0%0.01%0.0%
Q1 2015$109,000
-14.8%
68,015
-0.1%
0.01%
-23.5%
Q4 2014$128,000
+54.2%
68,115
+7.9%
0.02%
+54.5%
Q3 2014$83,000
-6.7%
63,115
+5.0%
0.01%
-15.4%
Q2 2014$89,000
-12.7%
60,1150.0%0.01%
-31.6%
Q1 2014$102,000
-18.4%
60,1150.0%0.02%
-13.6%
Q4 2013$125,000
-6.7%
60,115
+19.2%
0.02%
-24.1%
Q2 2013$134,00050,4200.03%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q4 2015
NameSharesValueWeighting ↓
Platinum Management (NY) LLC 10,375,329$13,549,00019.76%
Catalyst Capital Advisors LLC 790,000$1,635,0000.53%
DSC Advisors, L.P. 500,000$1,035,0000.50%
STONERIDGE INVESTMENT PARTNERS LLC 142,528$295,0000.06%
Hudock, Inc. 30,500$63,0000.05%
BRR OpCo, LLC 52,700$109,0000.05%
TFS CAPITAL LLC 418,074$865,0000.04%
LifePlan Financial Group, Inc 28,810$60,0000.04%
NOMURA HOLDINGS INC 3,831,177$7,947,0000.04%
BOLTON LP 77,400$160,0000.03%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders